Healthequity (HQY) Income towards Parent Company (2013 - 2026)

Healthequity's Income towards Parent Company history runs 14 years deep, the most recent figure standing at $69.4 million for Q2 2026.

• In Q2 2026, Income towards Parent Company rose 28.75% year-over-year to $69.4 million; the TTM figure through Apr 2026 stood at $230.7 million (up 89.44% YoY), while the FY2026 annual figure was $215.2 million, up 122.54% from the prior year.
• Income towards Parent Company was $69.4 million for Q2 2026 at Healthequity, up from $49.7 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $69.4 million in Q2 2026 to a low of -$32.8 million in Q1 2022.
• Historically, Income towards Parent Company has averaged $21.0 million across 5 years, with a median of $20.5 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Income towards Parent Company slumped 711.48% in 2022, then soared 12714.35% in 2024.
• A 5-year view of Income towards Parent Company shows it stood at -$1.6 million in 2022, then surged by 994.15% to $14.7 million in 2023, then plunged by 61.13% to $5.7 million in 2024, then jumped by 807.1% to $51.7 million in 2025, then soared by 34.19% to $69.4 million in 2026.
• The last three Income towards Parent Company figures came in at $69.4 million (Q2 2026), $49.7 million (Q1 2026), and $51.7 million (Q4 2025), per Business Quant data.